A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
Clinical trial NCT06591468 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06591468
- Sponsor
- Han Ying
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-12-31
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.